October 22, 2025 a 08:00 am
CVS: Fundamental Ratio Analysis - CVS Health Corporation
CVS Health Corporation is a key player in the healthcare sector, providing a wide array of services across retail, pharmacy, and insurance segments. With its extensive network of locations and a strong emphasis on healthcare benefits, CVS remains a vital part of the US health services landscape. Despite challenges, the company shows potential for stable growth and profitability in the coming years.
Fundamental Rating
CVS Health Corporation has been assessed as having a solid fundamental rating of A-. The scores across different categories indicate a stable financial foundation with some areas for improvement.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return On Equity | 3 | |
| Return On Assets | 4 | |
| Debt To Equity | 1 | |
| Price To Earnings | 3 | |
| Price To Book | 4 |
Historical Rating
The historical ratings reflect the company's progress over time. Recent ratings suggest consistency in its fundamental performance.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-10-21 | 4 | 5 | 3 | 4 | 1 | 3 | 4 |
| Previous Period | 0 | 5 | 3 | 4 | 1 | 3 | 4 |
Analyst Price Targets
The analyst price targets for CVS Health Corporation show optimism with a substantial upside potential. The consensus price is well above the current trading range.
| High | Low | Median | Consensus |
|---|---|---|---|
| $103 | $79 | $88.5 | $88.88 |
Analyst Sentiment
Analyst recommendations suggest a prevailing positive sentiment towards CVS Health Corporation, with a substantial number of 'Buy' and 'Strong Buy' ratings.
| Recommendation | Count | Distribution |
|---|---|---|
| Strong Buy | 2 | |
| Buy | 32 | |
| Hold | 7 | |
| Sell | 0 | |
| Strong Sell | 0 |
Conclusion
CVS Health Corporation demonstrates a resilient business model with stable financials and a strong market presence in the healthcare sector. The company's diversified operations provide a steady revenue stream, albeit challenges in managing debt levels persist. The positive analyst sentiment and favorable price targets indicate growth potential, although investors should remain vigilant of regulatory changes in the healthcare industry. Overall, CVS presents a compelling investment opportunity balanced by some inherent risks.